ID   Ltk-8-30-84
AC   CVCL_K239
DR   Wikidata; Q54903180
RX   Patent=US6706716;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-10421.
CC   Selected for resistance to: ChEBI; CHEBI:472552; 5-bromo-2'-deoxyuridine (Bromodeoxyuridine; BrdU; BUdR).
CC   Transfected with: HGNC; 5287; HTR1B.
CC   Derived from site: In situ; Connective tissue; UBERON=UBERON_0002384.
CC   Cell type: Fibroblast; CL=CL_0000057.
CC   Breed/subspecies: C3H/An.
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4536 ! L-M(TK-)
SX   Male
AG   100D
CA   Spontaneously immortalized cell line
DT   Created: 11-02-13; Last updated: 29-06-23; Version: 12
//
RX   Patent=US6706716;
RA   Konkel M., Wetzel J.M., Noble S.A., Gluchowski C., Craig D.A.;
RT   "Compounds specific for the human alpha1d adrenergic receptor and uses
RT   thereof.";
RL   Patent number US6706716, 16-Mar-2004.
//